Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Innovation in oncology clinical trial design.
Cancer treatment reviews·2019
Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug Development.
Hematology (Amsterdam, Netherlands)·2016
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials.
European journal of cancer (Oxford, England : 1990)·2015
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
Cancer chemotherapy and pharmacology·2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Long-term results of a randomised phase III trial of weekly versus three-weekly paclitaxel/platinum induction therapy followed by standard or extended three-weekly paclitaxel/platinum in European patients with advanced epithelial ovarian cancer.
European journal of cancer (Oxford, England : 1990)·2014
International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.
European journal of cancer (Oxford, England : 1990)·2026
Methodological considerations in the interpretation of ASCENT-03.
European journal of cancer (Oxford, England : 1990)·2026
Time-dependent recurrence patterns after curative resection for stage II/III colorectal cancer: An integrated analysis of four phase III randomized controlled trials (JCOG2310A-S4).
European journal of cancer (Oxford, England : 1990)·2026
Validation of the lung immune prognostic index in extensive-stage small cell lung cancer: Post hoc analysis of the caspian and IMpower133 phase 3 trials.
European journal of cancer (Oxford, England : 1990)·2026
Temporal linguistic shifts in oncology randomized controlled trials following large language model availability: A corpus analysis of 21,392 publications.
European journal of cancer (Oxford, England : 1990)·2026
Development and feasibility of the AO spinal metastasis staging (SMS) referral tool: An international multidisciplinary expert panel and survey study.
European journal of cancer (Oxford, England : 1990)·2026